ISO-1-3 Mutational status in the PI3K/AKT pathway and efficacy of mTOR inhibitors alone or combined with chemotherapeutics in ovarian clear cell carcinoma cells(Group 1 Oncology 1,IS Award Candidate,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-02-01
著者
-
YOSHIKAWA Hiroyuki
University of Tokyo
-
Ochi Hiroyuki
University of Tsukuba
-
Oki Akinori
Ibaraki Prefectural Central Hospital
-
Minaguchi Takeo
University of Tsukuba
-
Akiyama Azusa
University of Tsukuba
-
Nakamura Yuko
University of Tsukuba
-
Tasaka Nobutaka
University of Tsukuba
-
Yoshikawa Tomoyuki
University of Tsukuba
-
Sakurai Manabu
University of Tsukuba
-
Onuki Mamiko
University of Tsukuba
-
Matsumoto Koji
University of Tsukuba
-
Satoh Toyomi
University of Tsukuba
関連論文
- S-3 Aberrant expression of the FHIT gene in primary cervical carcinoma
- ISO-1-3 Mutational status in the PI3K/AKT pathway and efficacy of mTOR inhibitors alone or combined with chemotherapeutics in ovarian clear cell carcinoma cells(Group 1 Oncology 1,IS Award Candidate,International Session)
- ISP-11-3 Safety of elective induction of labor in breech vaginal delivery(Group 11 Perinatology 3,IS Poster,International Session)